During a scientific symposium held in Hanoi, domestic and international medical experts discussed the crucial shift in managing lung cancer, moving from a treatment-centric approach to proactive prevention and early diagnosis.
Statistical data indicates that lung cancer remains one of the deadliest malignancies in Vietnam. Annually, the country records approximately 24,400 new cases and over 22,200 deaths. A major obstacle to improving treatment outcomes is that roughly 75% of patients are diagnosed at advanced stages, resulting in high medical costs and low recovery prospects.
International specialists from Japan and Malaysia emphasized that implementing screening programs for high-risk groups could reduce mortality rates by 20% to 30%. Experience from developed nations shows that integrating Artificial Intelligence (AI) into the analysis of X-rays and low-dose computed tomography (LDCT) scans is an effective strategy for identifying early abnormalities.
Looking ahead, Vietnam’s healthcare sector will focus on sustainable solutions:
-
Controlling environmental and occupational risk factors while reducing the impact of tobacco.
-
Developing screening models tailored to the domestic economy and epidemiological data.
-
Utilizing digital technology and AI to standardize diagnostic procedures.
-
Enhancing data connectivity between preventive medicine facilities and the clinical treatment system.